Clinical Trials on Allergic Sensitisation

Total 2540 results

ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy

Allergic Rhinoconjunctivitis

Spain
Immunomic Therapeutics, Inc.

Completed

A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid

Allergic Rhinoconjunctivitis

United States
Faes Farma, S.A.
Merck Sharp & Dohme LLC; Allied Research International

Completed

Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR

Hypersensitivity | Allergic Conjunctivitis | Seasonal Allergic Rhinitis | Hay Fever

United States
Badalona Serveis Assistencials
Department of Health, Generalitat de Catalunya

Recruiting

VR-Enhanced Psychoeducation for Chronic Pain: A Primary Care Pilot Study (REDOCVR)

Chronic Pain | Central Sensitization

Spain
Vrije Universiteit Brussel

Completed

Prognostic Factor Research of Sensory Profiles in Development of Central Sensitization

Low Back Pain | Central Sensitisation | Sensory Profiles | Nociplastic Pain

Belgium
Ahn-Gook Pharmaceuticals Co.,Ltd
Samsung Medical Center; Seoul St. Mary's Hospital; Seoul National University... and other collaborators

Completed

Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean

Allergic Rhinitis | Perennial Allergic Rhinitis | Non-seasonal Allergic Rhinitis

Korea, Republic of
China Medical University Hospital

Withdrawn

Oral Probiotics to Allergic Pregnant Mother and Their Offspring to Prevent Allergic Disease

Allergic Diseases

Taiwan
ALK-Abelló A/S

Completed

Avanz Phleum Pratense Maintenance Dose

Allergic Rhinoconjunctivitis

Germany
UCB Pharma

Completed

Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites

Rhinitis | Allergic | Perennial
UCB Pharma

Completed

A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen

Rhinitis | Allergic | Seasonal

Canada
Medical University of Graz

Recruiting

Nasal Mucus Proteome and Immunotherapy

Allergic Rhinoconjunctivitis

Austria
Immunomic Therapeutics, Inc.

Completed

A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects

Allergic Rhinoconjunctivitis

United States
University of Zurich

Completed

Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration (ZU-SkinSIT-003)

Allergic Rhinoconjunctivitis

Switzerland
United Allergy Services

Completed

The Efficacy & Safety of the UAS Immunotherapy Protocol

Perennial Allergic Rhinitis With Seasonal Variation

United States
Eli Lilly and Company

Not yet recruiting

A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)

Perennial Allergic Rhinitis (PAR)

United States
Glenmark Specialty S.A.

Completed

Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR) (GSP 301-304)

Seasonal Allergic Rhinitis (SAR)

United States
Federico II University
University of Campania "Luigi Vanvitelli"

Completed

Effectiveness Of Therapy With A Thermal Water Nasal Aerosol In Children With Seasonal Allergic Rhinitis

Allergic Rhinitis (Disorder)

Italy
Istanbul University - Cerrahpasa (IUC)

Recruiting

Sensorial Discrimination in Chronic Low Back Pain

Back Pain | Chronic Pain | Central Sensitisation

Turkey
Silesian Centre for Heart Diseases

Unknown

Metal Allergy In-Stent Restenosis Study (RESTALL)

Coronary Artery Disease | Restenoses, Coronary | In-stent Restenosis | Contact Allergy | Metal Allergy
Glenmark Specialty S.A.

Completed

Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR) (GSP 301-305)

Seasonal Allergic Rhinitis (SAR)

United States
Teva Branded Pharmaceutical Products R&D, Inc.
United BioSource, LLC

Completed

Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis (BALANCE)

Perennial Allergic Rhinitis (PAR)

United States
Peking University Third Hospital

Recruiting

Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children

Children | Allergic Disease

China
Tanja Todberg, MD

Unknown

Anti-IL-17 a New Treatment for Contact Dermatititis

Allergic Contact Dermatitits

Denmark
National Center for Research Resources (NCRR)

Unknown

Classical Conditioning to Treat Allergic Airway Diseases

Allergic Airway Disease

United States
University Hospital, Strasbourg, France

Withdrawn

Role of Indoor Pollutants on House Dust Mite Allergic Asthma

Allergic Asthma | Allergy to House Dust Mite

France
University of Turku
Academy of Finland

Unknown

Pre-, Peri- and Postnatal Programming and Origins of Disease: Early Targeting the Epidemics of Allergy and Overweight (NAMI)

Obesity | Immunology | Allergic Disease

Finland
University of Zurich
University of Aarhus

Active, not recruiting

Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract

Allergic Rhinitis Due to Grass Pollen | Allergic Rhinitis | Rhinitis, Allergic, Seasonal | Allergic Asthma | Rhinitis; Allergic, With Asthma

Switzerland
AstraZeneca

Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

Allergic Rhinitis | Perennial Allergic Rhinitis | Hay Fever

United States
MASK-air SAS

Completed

Interaction Between Air Pollution, Pollens and Allergic Rhinitis (MISTRAL)

Allergic Rhinitis Due to Pollen | Allergic Rhinitis With Asthma

France
University Hospital Inselspital, Berne

Completed

Analgesic Effect of Oxytocin Receptor Modulation

Pain | Central Sensitization | Hyperalgesia

Switzerland
Vistakon Pharmaceuticals

Completed

Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers

Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis

United States
KK Women's and Children's Hospital

Recruiting

Evaluation of Central Sensitization, Fear-Avoidance, and Pain-Pressure Threshold With Chronic Pain After Hysterectomy (EPOCH)

Chronic Pain | Anxiety Depression | Hysterectomy | Central Sensitisation

Singapore
Marwa Elsayed
MTI University

Completed

Effect of Cognitive Behavioral Therapy on Chronic Low Back Pain With Sensitization

Chronic Low Back Pain | Central Sensitisation

Egypt
University of South Florida

Completed

Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis (EE)

Eosinophilic Esophagitis | Food Allergies

United States
Michel Bouvier
Clinique Charcot; Polyclinique du Beaujolais

Completed

Efficacy of Oral Tolerance Induction to Raw Apple (RAAP)

Oral Allergic Syndrome | Allergic Reaction Caused by Food (Disorder)
Atılım University

Not yet recruiting

Efficiency of Manual Therapy on Central Sensitization in Patients With Nonspecific Chronic Back Pain

Central Sensitization | Manual Therapy

Turkey
Organon and Co

Completed

Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284)

Allergic Airway Disease
Marinomed Biotech AG

Completed

Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray

Allergic Rhinitis | Allergic Conjunctivitis | Hayfever

Austria
AstraZeneca

Completed

Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)

Allergic Rhinitis | Perennial Allergic Rhinitis | Hay Fever

United States
AstraZeneca

Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)

Allergic Rhinitis | Perennial Allergic Rhinitis | Hay Fever

United States, Canada
AOBiome LLC
Integrium; Orange County Research Center

Completed

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis

Allergic Rhinitis Due to Grass Pollen | Allergic Rhinitis | Healthy Volunteers

United States, Canada
AstraZeneca

Completed

Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)

Perennial Allergic Rhinitis | Hay Fever

United States
Telios Pharma, Inc.

Recruiting

A Study Of TL-925 For The Treatment of AC

Allergic Conjunctivitis

United States
Telios Pharma, Inc.

Recruiting

A Study of TL-925 for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Noveome Biotherapeutics, formerly Stemnion

Completed

Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Faes Farma, S.A.
ORA, Inc.

Completed

A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.

Allergic Conjunctivitis

United States
Ocular Therapeutix, Inc.

Completed

A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Shire

Completed

Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis

Allergic Conjunctivitis

United States
ORA, Inc.

Completed

Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model

Allergic Conjunctivitis

United States
Aciex Therapeutics, Inc.

Completed

Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model

Allergic Conjunctivitis

United States

Clinical Trials on Allergic Sensitisation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations